CNews – Interview of Alain Moussy
Alain Moussy is interviewed by Sophie de Menthon in the show “Patrons en Question”.
Audio replay of the June 30 2021 Combined Shareholders’ Meeting
Replay of the audio transcript in the audio player below: https://www.ab-science.com/wp-content/uploads/2021/07/2021-07-01_AG_AB_Science_du_30_Juin_2021.mp3
Webcast presentation following the voluntary hold of clinical studies with masitinib
08/06/2021 : Presentation of the webcast that was held following the voluntary hold of clinical studies with masitinib
Masitinib in Prostate Cancer Webcast Presentation
25/05/2021 – Presentation of the webcast held on May 25, 2021 on masitinib in prostate Cancer Download PDF
Boursorama interview of Alain Moussy, CEO of AB Science
23/12/2020 – Read the interview of Alain Moussy, CEO of AB Science, in Boursorama
Equity financing for a maximum of 4 million shares with Alpha Blue Ocean’s PACT
16/11/2020 – AB Science secures equity financing for a maximum of 4 million shares with Alpha Blue Ocean’s PACT
Financing of 4.5 million euros through the issuance of bonds convertible into new ordinary shares
29/10/2020 – AB Science announces a financing of 4.5 million euros through the issuance of bonds convertible into new ordinary shares
Positive top-line Phase 3 results for oral masitinib in severe asthma
20/10/2020 – AB Science announces positive top-line Phase 3 results for oral masitinib in severe asthma
Results from masitinib study AB07015 in severe asthma selected for presentation at an American Thoracic Society symposium
13/10/2020 – Results from masitinib study AB07015 in severe asthma selected for presentation at an American Thoracic Society (ATS) symposium held on October 16, 2020
First half of 2020 results
30/09/2020 – AB Science reports its revenues for the first half of 2020